Drugs / Flotegatide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02325349 | Mar 2015 → Sep 2018 | head and neck carcinoma, non-small cell lung carcinoma | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flotegatide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02325349 ↗ |
| Modality | Diagnostic / imaging agent | “diagnostic radiopharmaceutical” NCT02325349 ↗ |
| Route | Intravenous | “intravenous administration” NCT02325349 ↗ |